
OCULAR THERAPEUTIX, INC
OCULAR THERAPEUTIX, INC (OCUL)
WebsitePrice
Market cap
Next catalystSOL-R topline in Q1 2028 after key secondary endpoint evaluationAXPAXLI — wet AMD: SOL-1, SOL-R and SOL-X · Phase 3 dataSEC filing ↗
Cash

OCULAR THERAPEUTIX, INC